Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Safety|June 17, 2017
Dual antiretroviral therapy for HIV infectionVicente Soriano, Jose Vicente Fernandez-Montero, Laura Benitez-Gutierrez, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 3, 2015
Drug interactions with new hepatitis C oral drugsVincent Soriano, Pablo Labarga, Pablo Barreiro, et al.
Antiviral Research|November 14, 2012
The changing face of hepatitis C in the new era of direct-acting antiviralsVincent Soriano, Pablo Labarga, Jose V Fernández-Montero, et al.
The Journal of Infectious Diseases|September 4, 2010
Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infectionJudit Morello, Lorena Cuenca, Vincent Soriano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patientsBelén Ramos, Marina Núñez, Luz Martín-Carbonero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2010
Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C Virus coinfected patients with prior nonresponse or relapsePablo Labarga, Eugenia Vispo, Pablo Barreiro, et al.
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for hepatitis CVincent Soriano, Antonio Madejon, Eugenia Vispo, et al.
The Journal of Antimicrobial Chemotherapy|December 25, 2009
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis CEugenia Vispo, Alvaro Mena, Ivana Maida, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|August 9, 2011
[The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up]Paz Sobrino-Vegas, Félix Gutiérrez, Juan Berenguer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2011
HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individualsNorma I Rallón, Vincent Soriano, Clara Restrepo, et al.
Pageof 11